GENFLOW BIOSCIENCES PLC Cash Flow-to-Debt Ratio
GENFLOW BIOSCIENCES PLC cash flow-to-debt ratio. GENFLOW BIOSCIENCES PLC (WQ5) has a Cash Flow-to-Debt Ratio of -1.37x as of December 2024, meaning its operating cash flow of €-1.08 Million could theoretically repay -1% of its total liabilities (€788.92K) in one year. See how financially flexible is GENFLOW BIOSCIENCES PLC to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GENFLOW BIOSCIENCES PLC (2021–2024)
Cash flow-to-debt ratio of GENFLOW BIOSCIENCES PLC from 2021 to 2024. Historical debt coverage capacity for GENFLOW BIOSCIENCES PLC across 4 annual periods. Also explore WQ5 net asset momentum to track the company's year-over-year net asset growth rate.
GENFLOW BIOSCIENCES PLC Cash Flow-to-Debt Ratio by Year (2021–2024)
GENFLOW BIOSCIENCES PLC cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for GENFLOW BIOSCIENCES PLC. For the full cash flow conversion analysis, see how efficiently does GENFLOW BIOSCIENCES PLC generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.37x | €-1.08 Million | €788.92K | ▲ +52.8% |
| 2023 | -2.90x | €-1.66 Million | €571.96K | ▲ +46.7% |
| 2022 | -5.45x | €-1.37 Million | €250.99K | ▼ -61.5% |
| 2021 | -3.38x | €-747.38K | €221.43K | — |